HIMSS Analytics recognizes Duke Health for their recent validation at stage 7, as tracked by the Adoption Model for Analytics Maturity (AMAM)
How are you working to take your organization’s advanced analytical capabilities to the next level? “With technology,” some might say – but what about the mass amounts of information staff and providers are putting in and taking out of these systems? That’s where things get tricky.
Health systems across the world are facing significant challenges when it comes to deploying advanced analytics successfully, as well as streamlining the flow of information from providers to patients and beyond. Many across the health IT sphere are still learning how our health IT systems can streamline care delivery and in turn, improve patient outcomes. We have all the data at our fingertips – but how do we tap into the more complex side of these systems with advanced analytics capabilities?
Duke Health, in Durham North Carolina, was able to do so with the help of the Adoption Model for Analytics Maturity (AMAM℠) – and in February 2018, they were the very first healthcare organization in the world to validate at Stage 7 AMAM status, the highest honor for analytics capabilities recognized by HIMSS Analytics.
In benchmarking against the AMAM, Duke Health demonstrated how they streamlined care delivery and improved patient outcomes, documenting these accomplishments in three case studies which evidenced the positive impact advanced analytics have on workflows.
One of these case studies, An Analytics-Driven Approach to Reduce Necrotizing Enterocolitis (NEC) in Extremely Premature Infants, is a direct result of Duke Health’s desire to combat Necrotizing Enterocolitis (NEC) which was appearing at higher rates compared to rates at similar neonatal intensive care units (NICUs). NEC is a catastrophic intestinal complication that occurs primarily in extremely premature infants born 12 or more weeks before term gestation.
Determined to improve these outcomes, Duke Health worked together to identify internal practice changes that could impact intestinal development and health to reduce these incidences. Duke Health providers and data scientists leveraged advanced analytics to assess current practice, develop consistent evidence-based guidelines, and track implementation of modified practices including reducing empirical antibiotic use, enhancing support of mothers providing their breastmilk for their preterm infants, developing consistent transfusion guidelines, and adopting stringent infection prevention protocols.
To build and maintain persistent and effective adoption of targeted practice changes, Duke Health created a data-driven approach using a combination of variation analyses, cost analyses, and multivariable analyses to assess changes, and quantify benefits. This has led to a significant drop in the NEC incidence. Advanced analytics techniques applied to an even larger array of clinical data are currently being used to identify novel risk factors and preventive strategies to further reduce NEC risk.
HIMSS Analytics AMAM Stage 7 Validation
HIMSS Analytics is pleased to recognize Duke Health for their Stage 7 AMAM status – the first organization to have coveted this honor.
“I am extremely proud of this recognition, because it underscores the multidisciplinary teamwork needed to deploy advanced analytics solutions that serve our patients, our physicians, and our community," said Jeffrey Ferranti, M.D., vice president and chief information officer, professor of pediatrics and medical informatics. “These solutions require a tight partnership between clinicians, operational leaders, informaticians, and statisticians. Our journey to AMAM Stage 7 allowed us to foster these relationships, and build the collaborative teams necessary to improve health through analytics.”
“Duke Health continues to lead healthcare with their innovative and progressive Analytics Center of Excellence (ACE) as well as promoting a strong analytics culture that both enables and encourages data driven decision making for the betterment of care,” said James E. Gaston, MBA, FHIMSS, Sr. Director, healthcare Advisory Services Group, HIMSS Analytics.
Duke Health conceptually integrates the Duke University School of Medicine, Duke-NUS Medical School, Duke University School of Nursing, Duke University Health System, Private Diagnostic Clinic (Duke physicians practice), and incorporates the health and health research programs within the Duke Global Health Institute as well as those in schools and centers across Duke University, including the Duke Robert J. Margolis Center for Health Policy. More information is available here.
HIMSS Analytics is a global healthcare technology market intelligence, research and standards organization assisting clientele in both healthcare delivery and healthcare technology solutions business development to make lasting improvements in efficiency and performance.
Maura Bilek | HIMSS North America
firstname.lastname@example.org 1 (312) 915-9510
Kyle Munderville | HIMSS Analytics
Kyle.Munderville@himssanalytics.org 1 (802) 657-6724